Drug Information

Drug General Information
Drug ID
D08JAC
Former ID
DIB003719
Drug Name
Fenretinide
Synonyms
RT-101; ST-602; SYT-101; Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University; LXS/4-HPR; Fenretinide (Ewing's sarcoma), Cancer Research UK; Fenretinide (ILE formulation), Children's Hospital LA; Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles; Fenretinide (intravenous, cancer), SciTech Development; Fenretinide (iv), Children's Hospital LA; Fenretinide (oral, AMD), Sytera; Fenretinide (soft gel capsule, AMD), ReVision Therapeutics; Fenretinide (soft gel capsule, AMD), Sirion; Fenretinide (topical, actinic keratosis and cancer), SciTech Development; N-(4-hydroxyphenyl)retinamide; Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx; Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products; 4-HPR
Drug Type
Small molecular drug
Indication Macular degeneration [ICD9: 362.5; ICD10:H35.3] Phase 3 [521449]
Company
Sirion Therapeutics; cerrx; Sytera Inc
Formula
C26H33NO2
Canonical SMILES
C1(=C(CCCC1(C)C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc1ccc(cc1)O)<br />/C)/C
CAS Number
CAS 65646-68-6
PubChem Compound ID
5288209
Target and Pathway
Target(s) Retinoic acid receptor Target Info Modulator [550397]
References
Ref 521449ClinicalTrials.gov (NCT00003075) Fenretinide in Treating Patients With Cervical Neoplasia. U.S. National Institutes of Health.
Ref 550397National Cancer Institute Drug Dictionary (drug id 39582).